Medtronic to create European software hub in Ireland

The investment in cardiac digital health will add 85 jobs initially, with more growth expected over the next three years.

By Susan Kelly • May 22, 2026

Intuitive readies 100 updates and improvements for da Vinci 5

Some updates to Intuitive’s surgical robot aim to improve communication between remote and on-site physicians to expand education opportunities.

By Nick Paul Taylor • May 22, 2026

Explore the Trendline➔

New medical devices are reshaping the medtech industry

From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

By MedTech Dive staff

Sentante lands Europe’s CE mark for endovascular robot

The Lithuania-based robotic surgery company is advancing a remote stroke system that was accepted into the FDA’s total product life cycle advisory program earlier this year.

By Susan Kelly • May 21, 2026

Medtronic to buy SPR Therapeutics for about $650M

Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

By Elise Reuter • May 20, 2026

Medtronic data back renal denervation in the long term

Analyses presented at EuroPCR assessed Medtronic’s Symplicity blood pressure procedure in patient groups with severe hypertension and who had prior cardiovascular events.

By Susan Kelly • May 20, 2026

Endologix buys clot removal system from Surmodics

Endologix will market the system to vascular interventionists who use its other devices to treat peripheral artery disease and abdominal aortic aneurysms.

By Nick Paul Taylor • May 20, 2026

Medtronic, BD name new leaders

Kweli Thompson will be promoted to head of Medtronic’s neuroscience portfolio, and Peter Menziuso will join BD’s interventional business. 

By Elise Reuter • May 19, 2026

Boston Scientific posts positive data for coronary IVL catheter

With the study results, Boston Scientific plans a regulatory submission for the intravascular lithotripsy treatment for patients with severely calcified coronary artery disease.

By Susan Kelly • May 19, 2026

Artivion closes Endospan buyout to acquire recently approved heart device

Artivion is targeting a $150 million annual U.S. market for the Nexus Aortic Arch System.

By Nick Paul Taylor • May 19, 2026

Boston Scientific buys $1.5B stake in TAVR developer MiRus

The deal gives Boston Scientific a 34% equity stake in MiRus and an option to acquire its TAVR platform by making additional payments totaling $3 billion.

By Susan Kelly • May 18, 2026

Embecta closes Owen Mumford acquisition for up to $201M

Embecta bought the company, which has an auto-injector platform, to expand outside of diabetes care.

By Elise Reuter • May 18, 2026

Dexcom to add 2 board directors with activist investor Elliott

CEO Jake Leach also discussed the company’s plans for its G8 glucose sensor, dual-analyte sensing and Medicare coverage at an investor day.

By Elise Reuter • May 15, 2026

Carl Zeiss says restructuring could affect up to 1,000 jobs

A weak investment climate in the Americas contributed to declines in the German company’s intraocular lens business in the first half of its fiscal year.

By Susan Kelly • May 15, 2026

4 medtech manufacturers recall kits over problem with Medline syringes

AVID Medical, Aligned Medical Solutions, Medical Action Industries and American Contract Systems all sent notices to customers about convenience kits that contain recalled Medline angiographic syringes.

By Elise Reuter • May 13, 2026

J&J launches improved Shockwave catheter

The latest generation of the coronary intravascular lithotripsy device is designed to be more flexible to help physicians navigate tight arteries to break up calcified deposits and restore blood flow.

By Susan Kelly • May 13, 2026

Bayesian Health gets FDA nod for AI sepsis detection tool

Created by Johns Hopkins University researchers, the early warning system for sepsis aims to help physicians detect the serious condition earlier.

By Elise Reuter • May 12, 2026

Stryker values Amplitude Vascular purchase at up to $835M

The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, includes $435 million upfront and up to $400 million in milestone payments.

By Susan Kelly • May 12, 2026

HistoSonics seeks FDA de novo authorization in kidney cancer

Investors including Bezos Expeditions and Thiel Bio supported HistoSonics’ expansion plans last year by participating in a $250 million financing round.

By Nick Paul Taylor • May 12, 2026

Medtronic to close California site amid restructuring

The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several businesses within its cardiovascular portfolio.

By Susan Kelly • May 11, 2026

Mobia Medical CEO eyes large market for stroke rehab

With a recent initial public offering, CEO Richard Foust hopes to make the company’s vagus nerve stimulation treatment the standard of care for stroke.

By Elise Reuter • May 11, 2026

BD appoints Vitor Roque as permanent CFO

The company made Roque’s appointment permanent after considering external candidates for the role.

By Nick Paul Taylor • May 11, 2026

Tandem to file tubeless insulin pump with FDA this quarter

The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device.

By Elise Reuter • May 8, 2026

Stryker closes Amplitude Vascular acquisition

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

By Susan Kelly • May 8, 2026

Roche to acquire digital pathology firm PathAI for up to $1.05B

Roche plans to offer PathAI’s tools as part of an effort to improve cancer diagnosis and tailored treatment.

By Elise Reuter • May 7, 2026

Neptune Medical’s GI robot succeeds in colonoscopy study

The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the beginning of the large intestine.

By Susan Kelly • May 6, 2026